Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
SANDU PHARMACEUTICALS LTD. | 183.97 | 5.56 | 183.73 | 0.57 | 51.8 | 35.2 |
GUJARAT TERCE LABORATORIES LTD | 127.48 | 10.08 | 126.81 | 1.36 | 50.2 | 17.0 |
Deccan Health Care Limited | 204.29 | 1.44 | 204.29 | 0.06 | 49.8 | 42.9 |
Sandu Pharmaceuticals Ltd., with Security Code 524703, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 16.7 | 17.0 | 15.2 | 17.6 | 16.6 | 17.4 | 15.5 | 17.0 | 17.7 | 18.3 |
Expenses | 15.9 | 16.3 | 14.8 | 17.3 | 15.8 | 16.9 | 15.0 | 16.6 | 16.8 | 17.4 |
Operating Profit | 0.9 | 0.8 | 0.5 | 0.4 | 0.8 | 0.5 | 0.6 | 0.4 | 0.9 | 1.0 |
OPM % | 5.14% | 4.8% | 3.16% | 2.01% | 4.97% | 2.94% | 3.88% | 2.38% | 5.18% | 5.39% |
Other Income | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 |
Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
Profit before tax | 0.9 | 0.7 | 0.4 | 0.2 | 0.8 | 0.4 | 0.7 | 0.3 | 0.7 | 0.8 |
Tax % | 31.7% | 31.1% | 27.5% | 47.9% | 27.9% | 45.2% | 17.4% | 38.4% | 32.8% | 30.4% |
Net Profit | 0.6 | 0.5 | 0.3 | 0.1 | 0.6 | 0.2 | 0.6 | 0.2 | 0.5 | 0.6 |
EPS in Rs | 0.64 | 0.52 | 0.27 | 0.11 | 0.57 | 0.21 | 0.5 | 0.17 | 0.52 | 0.57 |
Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|
Sales | 16.8 | 17.1 | 15.3 | 17.7 | 16.6 | 17.4 | 15.6 | 17.0 | 17.7 |
Expenses | 15.9 | 16.3 | 14.8 | 17.3 | 15.8 | 16.9 | 15.0 | 16.6 | 16.8 |
Operating Profit | 0.9 | 0.8 | 0.5 | 0.4 | 0.8 | 0.5 | 0.6 | 0.4 | 0.9 |
OPM % | 5.2% | 4.8% | 3.2% | 2% | 5% | 2.9% | 3.9% | 2.4% | 5.1% |
Other Income | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 |
Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
Profit before tax | 0.9 | 0.7 | 0.4 | 0.2 | 0.8 | 0.4 | 0.7 | 0.3 | 0.7 |
Tax % | 31.8% | 31% | 27.9% | 47.9% | 28% | 45.2% | 17.4% | 38.4% | 32.8% |
Net Profit | 0.6 | 0.5 | 0.3 | 0.1 | 0.6 | 0.2 | 0.6 | 0.2 | 0.5 |
EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | 5% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 17% |
3 Years: | 10% |
TTM: | 60% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 28% |
3 Years: | -2% |
1 Year: | -26% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 4% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 28% |
3 Years: | -2% |
1 Year: | -26% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
---|